Improvement of Re-examination System of New Drugs: A Safety Monitoring Study using Real-World Data on Re-examined Drugs
Journal of Pharmacoepidemiology and Risk Management · 2022
DOI: 10.56142/2022.14.1.58 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, 2022. Verfasst von Mi-Sook Kim und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, M., Jeong, N., Kim, Y., & Choi, N. (2022). Improvement of Re-examination System of New Drugs: A Safety Monitoring Study using Real-World Data on Re-examined Drugs. Journal of Pharmacoepidemiology and Risk Management. https://doi.org/10.56142/2022.14.1.58
Vancouver
Kim M, Jeong N, Kim Y, Choi N. Improvement of Re-examination System of New Drugs: A Safety Monitoring Study using Real-World Data on Re-examined Drugs. Journal of Pharmacoepidemiology and Risk Management. 2022. doi:10.56142/2022.14.1.58
BibTeX
@article{Kim2022,
author = {Kim, Mi-Sook and Jeong, Na-Young and Kim, Yohan and Choi, Nam-Kyong},
title = {Improvement of Re-examination System of New Drugs: A Safety Monitoring Study using Real-World Data on Re-examined Drugs},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2022},
doi = {10.56142/2022.14.1.58}
}
EUVIMED